Episode 124: Pharma's lobbying dollars, Alnylam's future, and diversity in Covid-19 studies
Is pharma scared of Kamala Harris? Are there seco…
August 13, 202026m 48s
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Is pharma scared of Kamala Harris? Are there second acts in biotech? And why don't Covid-19 trials look more diverse?